Key facts
- Notable investors include Kunshan Hi-tech Venture Capital, Huangpu Institute of Materials.
- Status: Privately Held (backing).
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Zhentai Biotechnology
- ·The full record, as it builds
Funding rounds
No funding rounds for Zhentai Biotechnology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Zhentai Biotechnology
Developer of multifunctional citric acid designed for biomaterials. The company's products primarily focus on the research and development of medical aesthetic raw materials, which include citric acid materials, collagen, and other compound products, as well as bovine Achilles tendon-extracted collagen and recombinant collagen. This provides customers with comprehensive and innovative products.
- Sector
- Healthcare
- HQ
- Guangzhou, China
- Founded
- 2023
- Website
- gdztsw.com/
- Ownership
- Privately Held (backing)
Zhentai Biotechnology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Zhentai Biotechnology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Zhentai Biotechnology in its N-PORT filings yet. We sweep new filings monthly.